Hui Peng: Clinical Trials

1 trial sponsored by Hui Peng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. .

Follow Hui Peng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration
Faricimab - Neovascular Age-related Macular Degeneration(nAMD)
Not yet recruitingHui Peng352025-09-012025-07-28

Interventions

faricimab (1)